Granules India Limited (GRANULES) - Financial and Strategic SWOT Analysis Review

Aug, 2016   |   41  Pages   |   GlobalData   |   Format : PDF

Granules India Limited (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing fa

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Granules India Limited - Key Facts 6
Granules India Limited - Key Employees 7
Granules India Limited - Key Employee Biographies 8
Granules India Limited - Major Products and Services 9
Granules India Limited - History 10
Granules India Limited - Company Statement 11
Granules India Limited - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 12
Section 2 - Company Analysis 13
Granules India Limited - Business Description 13
Granules India Limited - Corporate Strategy 14
Granules India Limited - SWOT Analysis 15
SWOT Analysis - Overview 15
Granules India Limited - Strengths 15
Strength - Leading Position 15
Strength - Focused Research & Development Activities 15
Strength - Increase in Products Sales 15
Granules India Limited - Weaknesses 16
Weakness - Declining Revenue: Latin America 16
Granules India Limited - Opportunities 17
Opportunity - Global Pharmaceutical Outsourcing Market 17
Opportunity - Expansion Initiatives 17
Opportunity - In-Licensing Agreement 17
Granules India Limited - Threats 18
Threat - Intense Competition 18
Threat - Stringent Government Regulations 18
Threat - Industry Consolidation 18
Granules India Limited - Key Competitors 19
Section 3 - Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 - Company's Lifesciences Financial Deals and Alliances 26
Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26
Granules India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27
Granules India Limited, Recent Deals Summary 28
Section 5 - Company's Recent Developments 29
Apr 28, 2016: Granules India : Revenue increases 11% to Rs. 1,431 Cr.; Net Profit surges 30% to Rs. 118 Cr 29
Jan 28, 2016: Granules India : Revenue increases 8% to Rs. 345 Cr.; Net Profit surges 15% to Rs. 27 Cr 30
Dec 21, 2015: Granules India's Two Facilities Located in Andhra Pradesh and Telangana Completed FDA Inspection 31
Oct 31, 2015: Granules India's Revenue increases 19% to Rs. 366 Cr.; Net Profit surges 40% to Rs. 31 Cr. 32
Jul 23, 2015: Granules India's Revenue increases 11% to Rs. 346 Cr.; Net Profit surges 19% to Rs. 27 Cr. 33
Apr 27, 2015: Granules India's FY15 Revenue increases 18% to Rs. 1,293 Cr.; Net Profit rises 21% to Rs. 91 Cr 34
Mar 16, 2015: FDA Inspects Granules India's Gagillapur Facility 35
Jan 28, 2015: Granules India's Revenue increases 13% to Rs. 320 Cr.; Net Profit rises 8% to Rs. 24 Cr. 36
Section 6 - Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Granules India Limited, Key Facts 6
Granules India Limited, Key Employees 7
Granules India Limited, Key Employee Biographies 8
Granules India Limited, Major Products and Services 9
Granules India Limited, History 10
Granules India Limited, Subsidiaries 12
Granules India Limited, Joint Venture 12
Granules India Limited, Key Competitors 19
Granules India Limited, Ratios based on current share price 20
Granules India Limited, Annual Ratios 21
Granules India Limited, Interim Ratios 24
Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26
Granules India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27
Granules India Limited, Recent Deals Summary 28
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List of Figures
Granules India Limited, Performance Chart (2012 - 2016) 23
Granules India Limited, Ratio Charts 25
Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26
Granules India Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 27

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Follow Us On: